The NZNO Cancer nurses programme runs on Friday 25 October. All nurses are welcome to join on the Saturday, however you must ensure you register as a full delegate when completing the registration process.  

Please note the Programme is subject to change.

Thursday 24 October

9.30am - 5.00pm

Cancer Trials New Zealand Annual Scientific Meeting
The Loft, Harbourside Function Centre
Click here for the final programme

2.00pm - 5.00pm

Registration open

2.00pm - 4.00pm

Networking site pack in

5.00pm - 7.00pm Welcome drinks
Mac's Brewbar

Friday 25 October

 7.00am - 5.30pm
Registration desk open

 7.00am - 8.30am


Raising the bar for patient outcome: novel strategies in the era of immunotherapy
Prof Rod Dunbar, The University of Auckland, Dr Annie Wong, Peter MacCallum       

Kindly sponsored by MSD                  

 8.30am Conference opening

Session one: Research in a local context



Chair introduction          
Dr Melanie McConnell, Dr Kate Clarke 

 9.10am Doctors in Denial: The forgotten women in the 'unfortunate experiment'
Prof Ron Jones


Building capability for nurse-led cancer research. Development, implementation and impact of a multi-site initiative
Prof Mei Krishnasamy, University of Melbourne           


Morning tea

Session two: Equity



Chair introduction
Dr Melanie McConnell     



Hard Facts and Home Truths: Inequities in cancer incidence, mortality and survival for Maori
Dr Jason Gurney, University of Otago


Inequity in New Zealand – role of research and researchers to improve equity outcomes in cancer
Dr Chris Jackson, Southern DHB, Assoc Prof Jonathan Koea, Ngati mutunga, Ngati tama, Dr Juliet Rumball-Smith, Dr Jason Gurney, University of Otago

Mapping a route to Maori engagement for clinical cancer genomics
Dr Kimiora Henare, Auckland Cancer Society Research Centre 



Session three: Bruce Cain Memorial Lecture

  Chair introduction
Sarah Barton

Prof Sherene Loi, Peter MacCallum Cancer Centre

 2.00pm Debate: Every cancer patient should have comprehensive genomics performed as standard of care
For: Prof Parry Guilford, University of Otago
Against: Dr Kate Clarke, CCDHB
Debate kindly sponsored by Roche
 2.30pm Afternoon tea

Session four: PHARMAC Emerging Researcher Awards

  Presentations are 7 minutes each with a short break between each for judging and introductions

Chair introduction
Dr Kate Clarke, Dr Kirsty Danielson 


Pembrolizumab Adverse Events in the MidCentral Regional Cancer Treatment Service
Dr Lucy Watt, MidCentral DHB

Tumour Evolution through Time and Space: A Genomic Journey
Tamsin Robb, University of Auckland       

Neoadjuvant Chemotherapy in Non-Metastatic Breast Cancer- A Study on Practice Trends in a Regional Cancer Treatment Service
Dr Edmond Ang, Auckland City Hospital
Applied single molecule genotyping for high throughput quantification of intercellular mitochondrial transfer in injury models of neural cell stress
Matt Rowe, Victoria University



Outcomes of Elderly Medical Oncology Patients Treated with Chemotherapy at Rotorua Hospital
Dr Pragya Attri, Lakes DHB 



Tumour Burden Impairs Skeletal Muscle Adaptations to Exercise in Mice
Linda Buss, University of Otago 



A prospective audit on use of prophylactic anti-emetics and rates of CINV in patients receiving carboplatin AUC?4 or combination anthracycline/cylophosphamide
Dr Edward Lo, MidCentral RCTS 



In pursuit of precision: determinants of sensitivity and resistance to trastuzumab emtansine in HER2-positive breast cancer
Hilary Barker, University of Auckland 

 4.30pm - 5.30pm Poster session with drinks and canapes
 6.30pm onwards
Conference dinner
The Boatshed

Saturday 26 October

8.00am - 3.30pm Registration desk open
8.30am NZSO AGM

Session five: Immunotherapy


Chair introduction
Assoc Prof Roslyn Kemp, Dr Annie Wong                                    

 9.35am TNF in anti-tumour immunity and resistance to immunotherapy
Dr Jane Oliaro, Peter MacCallum Cancer Centre
 10.05am Chimeric antigen receptor t-cells: the enable trial
Dr Rob Weinkove, Malaghan Institute of Medical




Combination Treatment with Letrozole, anti-PD-1, and Cancer Vaccine Decreases Tumour Growth in a Murine Model of Oestrogen Receptor-Positive Breast Cancer
Dr Kate Powell, University of Otago



Global DNA methylation levels regulate expression of immune checkpoint PD-L1 in melanoma
Dr Aniruddha Chatterjee, University of Otago



A Spatial Proteomics Approach to Understanding the Immune Microenvironment in  Merkel Cell Carcinomas
Dr Cherie Blenkiron
, University of Auckland

 11.05am Morning tea

Session six: Translational research

Chair introduction         
Dr Kirsty Danielson, Dr Ben Lawrence             
 11.40am Integrating translational research into practice for Lower GI cancers
Prof Sandy Heriot, Peter MacCallum Cancer Centre



MIFtifying Glioblastoma
A/Prof Kerrie McDonald, Cure Brain Cancer Foundation



SPARC is a potential biomarker for tumour regression following neoadjuvant chemoradiotherapy in locally advanced rectal cancer
A/Prof Chris Hemmings, Canterbury Health Laboratories

Plasma extracellular vesicle microRNA as biomarkers in early stage colorectal cancer
Dr Brendan Desmond, University of Otago


Session seven: Real world applications in research


Chair introduction
Dr Sarah Barton, Dr Bridget Robinson


Presentation of NZSO Translational Researcher Award




NZSO Translational Researcher Award Lecture: Equity, evolution and expectation
Prof Parry Guilford



Deriving value from real-world data sets, initiatives and results from the Australasian Lymphoma Alliance
Dr Eliza Hawkes, Olivia Newton- John Cancer Centre 



2018 Roche Translational Cancer Research Fellowship recipient presentation
Dr Andrew Das


Conference close and student poster award presentations




Dr Kate ClarkeNZSO President

A/Prof Margaret CurrieVice President

Ken Dempster NZSO Membership

Charlotte Emery Conference and Website